72 related articles for article (PubMed ID: 2436628)
21. [Antigenic structure of the foot-and-mouth virus. V. Protection of naturally susceptible animals from foot-and-mouth disease using a synthetic peptide].
Iarov AV; Gel'fanov VM; Grechaninova LA; Surovoĭ AIu; Vol'pina OM; Ivanov VT; Chepurkin AV; Driagalin NN; Ivaniushchenkov VM
Bioorg Khim; 1989 Oct; 15(10):1313-7. PubMed ID: 2561049
[TBL] [Abstract][Full Text] [Related]
22. [Antigenic structure of the foot-and-mouth-disease virus. I. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth virus type O1K].
Surovoĭ AIu; Vol'pina OM; Snetkova EV; Volkova TD; Ivanov VT
Bioorg Khim; 1988 Oct; 14(10):1352-62. PubMed ID: 2852937
[TBL] [Abstract][Full Text] [Related]
23. Antigenically profound amino acid substitutions occur during large population passages of foot-and-mouth disease virus.
Sevilla N; Verdaguer N; Domingo E
Virology; 1996 Nov; 225(2):400-5. PubMed ID: 8918927
[TBL] [Abstract][Full Text] [Related]
24. Progress and perspectives in the development of a foot-and-mouth disease vaccine by recombinant DNA technology.
Brown F
Prog Vet Microbiol Immunol; 1987; 3():59-72. PubMed ID: 2483918
[No Abstract] [Full Text] [Related]
25. [Bacterial synthesis of immunogenic epitopes of foot-and-mouth disease virus fused either to human necrosis factor or to hepatitis B core antigen].
Nekrasova OV; Boĭchenko VE; Boldyreva EF; Borisova GP; Pumpen P; Perevozchikova NA; Korobko VG
Bioorg Khim; 1997 Feb; 23(2):118-26. PubMed ID: 9157845
[TBL] [Abstract][Full Text] [Related]
26. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity.
Kim SA; Liang CM; Cheng IC; Cheng YC; Chiao MT; Tseng CJ; Lee F; Jong MH; Tao MH; Yang NS; Liang SM
J Gene Med; 2006 Sep; 8(9):1182-91. PubMed ID: 16927362
[TBL] [Abstract][Full Text] [Related]
27. Genome analysis and development of infectious cDNA clone of a virulence-attenuated strain of foot-and-mouth disease virus type Asia 1 from China.
Xin A; Li H; Li L; Liao D; Yang Y; Zhang N; Chen B
Vet Microbiol; 2009 Sep; 138(3-4):273-80. PubMed ID: 19410387
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity of a recombinant fusion protein of tandem repeat epitopes of foot-and-mouth disease virus type Asia 1 for guinea pigs.
Zhang Q; Yang YQ; Zhang ZY; Li L; Yan WY; Jiang WJ; Xin AG; Lei CX; Zheng ZX
Acta Virol; 2002; 46(1):1-9. PubMed ID: 12199204
[TBL] [Abstract][Full Text] [Related]
29. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
Mayr GA; Chinsangaram J; Grubman MJ
Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
[TBL] [Abstract][Full Text] [Related]
30. Conformational preferences of a peptide corresponding to the major antigenic determinant of foot-and-mouth disease virus: implications for peptide-vaccine approaches.
de Prat-Gay G
Arch Biochem Biophys; 1997 May; 341(2):360-9. PubMed ID: 9169027
[TBL] [Abstract][Full Text] [Related]
31. Expression of an animal virus antigenic site on the surface of a plant virus particle.
Usha R; Rohll JB; Spall VE; Shanks M; Maule AJ; Johnson JE; Lomonossoff GP
Virology; 1993 Nov; 197(1):366-74. PubMed ID: 7692669
[TBL] [Abstract][Full Text] [Related]
32. Loss of antigenic epitopes as the result of env gene recombination in retrovirus-induced leukemia in immunocompetent mice.
Tumas KM; Poszgay JM; Avidan N; Ksiazek SJ; Overmoyer B; Blank KJ; Prystowsky MB
Virology; 1993 Feb; 192(2):587-95. PubMed ID: 7678475
[TBL] [Abstract][Full Text] [Related]
33. [Study on the DNA vaccine against foot-and-mouth disease virus using the heavy chain constant region of swine IgG as the carrier for peptide epitopes].
Li GJ; Yan WY; Xu QX; Sheng ZT; Zheng ZX
Sheng Wu Gong Cheng Xue Bao; 2001 May; 17(3):322-4. PubMed ID: 11517610
[TBL] [Abstract][Full Text] [Related]
34. Cloning of cDNA of major antigen of foot and mouth disease virus and expression in E. coli.
Küpper H; Keller W; Kurz C; Forss S; Schaller H; Franze R; Strohmaier K; Marquardt O; Zaslavsky VG; Hofschneider PH
Nature; 1981 Feb; 289(5798):555-9. PubMed ID: 6258084
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the amino acid sequence of the major immunogen from three serotypes of foot and mouth disease virus.
Makoff AJ; Paynter CA; Rowlands DJ; Boothroyd JC
Nucleic Acids Res; 1982 Dec; 10(24):8285-95. PubMed ID: 6298715
[TBL] [Abstract][Full Text] [Related]
36. Molecular cloning of foot and mouth disease virus genome and nucleotide sequences in the structural protein genes.
Boothroyd JC; Highfield PE; Cross GA; Rowlands DJ; Lowe PA; Brown F; Harris TJ
Nature; 1981 Apr; 290(5809):800-2. PubMed ID: 6261157
[TBL] [Abstract][Full Text] [Related]
37. The molecular basis of the antigenic variation of foot-and-mouth disease virus.
Beck E; Feil G; Strohmaier K
EMBO J; 1983; 2(4):555-9. PubMed ID: 6194987
[TBL] [Abstract][Full Text] [Related]
38. Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus.
Pfaff E; Mussgay M; Böhm HO; Schulz GE; Schaller H
EMBO J; 1982; 1(7):869-74. PubMed ID: 6203738
[TBL] [Abstract][Full Text] [Related]
39. Molecular cloning of cDNA from foot-and-mouth disease virus C1-Santa Pau (C-S8). Sequence of protein-VP1-coding segment.
Villanueva N; Dávila M; Ortín J; Domingo E
Gene; 1983 Aug; 23(2):185-94. PubMed ID: 6311686
[TBL] [Abstract][Full Text] [Related]
40. Molecular cloning and expression of the VP1 gene of foot-and-mouth disease virus C1 in E. coli: effect on bacterial cell viability.
Vidal M; Cairó J; Mateu MG; Villaverde A
Appl Microbiol Biotechnol; 1991 Sep; 35(6):788-92. PubMed ID: 1369359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
